Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Carna Biosciences

Market Cap: JP¥4.8b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

Kissei Pharmaceutical

Market Cap: JP¥151.5b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Ribomic

Market Cap: JP¥3.9b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

Solasia Pharma K.K

Market Cap: JP¥7.0b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

TMS

Market Cap: JP¥6.4b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Takara Bio

Market Cap: JP¥91.9b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Kringle Pharma

Market Cap: JP¥5.5b

Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.

SymBio Pharmaceuticals

Market Cap: JP¥7.2b

Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.

Chugai Pharmaceutical

Market Cap: JP¥10.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

CanBas

Market Cap: JP¥17.5b

A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.

CellSource

Market Cap: JP¥12.6b

Engages in the regenerative medicine-related businesses in Japan.

DNA Chip Research

Market Cap: JP¥7.3b

Develops DNA microarrays in Japan.

Kyowa Kirin

Market Cap: JP¥1.1t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Nippon Shinyaku

Market Cap: JP¥230.8b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Chordia Therapeutics

Market Cap: JP¥17.2b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Veritas In Silico

Market Cap: JP¥4.6b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

FunPep

Market Cap: JP¥3.3b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

Santen Pharmaceutical

Market Cap: JP¥445.3b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Noile-Immune Biotech

Market Cap: JP¥6.0b

Researches and develops CAR-T cells for cancer immunotherapies.

Seikagaku

Market Cap: JP¥35.5b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

WDB coco

Market Cap: JP¥7.8b

Provides contract services to pharmaceutical companies in Japan.

Shionogi

Market Cap: JP¥1.8t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Immuno-Biological Laboratories

Market Cap: JP¥4.0b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

ReproCELL

Market Cap: JP¥13.1b

Provides stem cell research and drug discovery services in Japan.

SanBio

Market Cap: JP¥130.0b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

Perseus Proteomics

Market Cap: JP¥6.2b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

Oncolys BioPharma

Market Cap: JP¥13.1b

Engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States.

OncoTherapy Science

Market Cap: JP¥6.5b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

MedRx

Market Cap: JP¥3.1b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Renascience

Market Cap: JP¥13.7b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

StemRIM

Market Cap: JP¥17.7b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Modalis Therapeutics

Market Cap: JP¥5.7b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

Heartseed

Market Cap: JP¥48.5b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Zeria Pharmaceutical

Market Cap: JP¥96.3b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.

Kaken Pharmaceutical

Market Cap: JP¥158.4b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Kubota Pharmaceutical Holdings

Market Cap: JP¥2.6b

Develops portfolio of drugs and devices worldwide.